Statins Could Mitigate VTE Risk in Women at Menopausal Age on Hormone Therapy
13 Jan 2024 • A JAMA study explored whether statin therapy mediates VTE risk in US women aged 50 to 64 years exposed to exogenous hormones.
In this case-control study of 223 949 women aged 50 to 64 years, the risk of VTE was 53% higher in women recently exposed to HT without current statin therapy and 25% higher in women with recent HT exposure and current statin therapy compared with women who were not exposed to recent HT or statins.
These findings suggest that statins may reduce risk of VTE in women exposed to HT and that HT may not be contraindicated in women taking statins.
Source: JAMA | Read full story